CRISPR Gene Editing Takes on Rare Immunodeficiency Disorder (IMAGE)

American Association for the Advancement of Science (AAAS)

CRISPR Gene Editing Takes on Rare Immunodeficiency Disorder

Caption

Researchers have harnessed the CRISPR-Cas9 technology to correct mutations in the blood stem cells of patients with a rare immunodeficiency disorder; the engineered cells successfully engrafted in mice for up to five months

Credit

Chris Bickel / <i> Science Translational Medicine </i>(2017)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.